Veracyte, Inc.
Nasdaq · Healthcare · Services-Medical Laboratories · South San Francisco, CA
VCYT chart
What traders are saying about $VCYT
Latest postsVeracyte, Inc. news
- Director Karin Eastham proposes selling 14,850 Veracyte (VCYT) shares.
Stock Titan ·
- How Investors May Respond To Veracyte (VCYT) Expanded Test Coverage
Simply Wall Street ·
- Veracyte’s Decipher May Guide Therapy Intensification But More Study Needed on Predictive Capability
GenomeWeb ·
- Veracyte, Inc. Estimates – MUN:12V
TradingView ·
- Veracyte stock: Veracyte presents 401-patient Decipher evidence for Veracyte stock
ad-hoc-news.de ·
- Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer
Yahoo Finance ·
- Veracyte: Strong Diagnostic Growth And Improving Margins (NASDAQ:VCYT)
Seeking Alpha ·
- Veracyte, Inc. (VCYT) Stock Forecasts
Yahoo Finance ·
- Veracyte director Muna Bhanji sells $81,456 in company stock By Investing.com
Investing.com South Africa ·
- Veracyte Inc (VCYT) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 80/100
GuruFocus ·
- Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?
Yahoo Finance ·
- Form 4 Veracyte Inc: Muna Bhanji (Director) For: 19 October By Investing.com
Investing.com India ·
Veracyte, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $517.1M | $445.8M | $361.1M | $296.5M |
| Net income | $66.4M | $24.1M | -$74.4M | -$36.6M |
| Diluted EPS | $0.82 | $0.31 | $-1.02 | $-0.51 |
| Total assets (year end) | $1.41B | $1.30B | $1.11B | $1.16B |
| Cash and equivalents (year end) | $362.6M | $239.1M | $216.5M | $154.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Veracyte, Inc.
- Ticker
- VCYT (Nasdaq)
- Industry
- Services-Medical Laboratories
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1384101
- Former names
- CALDEROME INC
Frequently asked questions
What exchange is Veracyte, Inc. listed on?
Veracyte, Inc. trades on the Nasdaq under the ticker symbol VCYT.
What industry is Veracyte, Inc. in?
Veracyte, Inc. is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.
Where is Veracyte, Inc. headquartered?
Veracyte, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Veracyte, Inc.'s fiscal year end?
Veracyte, Inc.'s fiscal year ends on December 31.
How much revenue did Veracyte, Inc. report?
Veracyte, Inc. reported $517.1M in revenue for calendar year 2025, according to its SEC filings.